SHYFT Analytics, a Medidata Solutions, today announced that Novartis has selected its Intelligent Platform for Life Sciences to support the commercialization of key therapies in Europe. As part of the collaboration, Novartis will use the following SHYFT solutions: - STRATA Data Platform to aggregate and manage a growing number of third party and proprietary commercial data sources- LUMEN Insights Platform to deliver intuitively-designed analytics to drive the “next-best-actions” for commercial
Read More
SHYFT Analytics
Medidata Acquires SHYFT Analytics for $195M to Power Digital Transformation in Life Sciences
Medidata today announced that it has entered into a definitive agreement to acquire SHYFT Analytics for $195 million in cash, closing the loop on clinical development with commercial and real-world data analytics. SHYFT Analytics cloud data analytics platform for life sciences provides insights on 45B patient records and 2M providers. Medidata's unified platform, pioneering analytics, and unrivaled expertise power the development of new therapies for over 1,000 pharmaceutical companies, biotech,
Read More
SHYFT Analytics Lands $12.5M Backed by McKesson Ventures, Medidata
SHYFT Analytics, a provider of cloud data and analytics for the global life sciences industry has raised $12.5 million in Series B funding. SHYFT Management opted for an all strategic collaboration, which included investments from McKesson Ventures, Medidata Solutions and other healthcare and technology industry leaders. SHYFT will use the investment to continue its rapid growth and expansion and further advance its leading healthcare cloud analytics platform. Existing investors, Health
Read More
